Abstract

Introduction

Patients’ attitudes and subjective experience are crucial in the management of severe mental illness, but their practical value is overlooked.

Objectives

To identify predictors of future adherence to LAI antipsychotic maintenance treatment of schizophrenia among socio-demographic, clinical, and psychometric characteristics – including Drug Attitude Inventory-10 (DAI-10) and Subjective Well-being under Neuroleptics short form (SWN-K) scores.

Methods

Retrospective baseline data from 53 clinically stable outpatients with schizophrenia switched from oral to LAI therapy were collected. Patients continuing treatment at the time of analysis (n=29) were compared to those who had discontinued it (n=24). Selected variables were further evaluated in survival analyses.

Results

Between-group differences are presented in Table 1 (**: p<0.01; *: p<0.05).

Continued treatmentDiscontinued treatmentχ2 or t
Treatment persistence (months)63.79±21.0123.88±25.806.21**
Age (years)39.17±10.1135.58±13.391.11
Male15 (51.7%)13 (54.1%)0.03
Single20 (69.0%)15 (62.5%)0.25
Instruction (years)13.28±3.3111.83±3.561.53
Employed20 (69.0%)7 (29.2%)8.32**
Illness duration (years)17.69±10.5313.42±11.361.42
Previous hospitalisations2.10±1.322.67±1.86-1.29
MADRS13.59±9.0614.67±8.99-0.43
YMRS5.52±5.576.00±9.94-0.22
p-PANSS12.17±5.2014.38±6.13-1.41
n-PANSS10.90±5.3915.63±7.93-2.48*
g-PANSS29.38±10.3333.63±10.26-1.49
PANSS52.66±17.5763.96±20.61-2.15*
DAI-103.86±4.96-1.13±5.803.38**
SWN-K74.93±23.0781.00±15.60-1.09

Cox regression analysis included instruction, employment, hospitalisations, PANSS subscales and DAI-10 scores: a protective role against treatment discontinuation was outlined only for employment (HR 0.16; 95%CI 0.05-0.50) and higher DAI-10 scores (HR 0.85; 95%CI 0.78-0.94). DAI-10 scores delineated distinct adherence trajectories (Figure 1).

Conclusions

Baseline DAI-10 scores may identify patients at risk of dropout after switching to LAI.

Disclosure

No significant relationships.

Details

Title
Drug attitude inventory is relevant to LAI treatment persistence in schizophrenia: Preliminary results
Author
G D’Anna 1 ; Tatini, L 1 ; Pietrini, F 2 ; Ballerini, A 1 ; Ricca, V 1 

 Department Of Health Sciences, University of Florence, Florence, Italy 
 Department Of Mental Health And Addictions, Central Tuscany NHS Trust, Florence, Italy 
Pages
S156-S156
Publication year
2021
Publication date
Apr 2021
Publisher
Cambridge University Press
ISSN
09249338
e-ISSN
17783585
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2560875942
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.